Caricamento...

Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities

Recent advances in immuno-oncology and regulatory approvals have been rapid and paradigm shifting in many difficult-to-treat malignancies. Despite immune checkpoint inhibitor therapy becoming the standard of care across multiple tumor types, there are many unanswered questions that need to be addres...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Baik, Christina S., Rubin, Eric H., Forde, Patrick M., Mehnert, Janice M., Collyar, Deborah, Butler, Marcus O., Dixon, Erica L., Chow, Laura Q.M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735832/
https://ncbi.nlm.nih.gov/pubmed/28864727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-3066
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !